Eric C. M. Van Gorp

941 total citations
17 papers, 713 citations indexed

About

Eric C. M. Van Gorp is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Eric C. M. Van Gorp has authored 17 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Eric C. M. Van Gorp's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Eric C. M. Van Gorp is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Eric C. M. Van Gorp collaborates with scholars based in Netherlands, Indonesia and Italy. Eric C. M. Van Gorp's co-authors include Jos H. Beijnen, Jan W. Mulder, Alwin D. R. Huitema, Pieter L. Meenhorst, Monique M. R. de Maat, Jiri F. P. Wagenaar, Albert T.A. Mairuhu, Rob ter Heine, Ron A. A. Mathôt and Marga G. A. Goris and has published in prestigious journals such as Emerging infectious diseases, AIDS and Pharmacological Research.

In The Last Decade

Eric C. M. Van Gorp

17 papers receiving 690 citations

Peers

Eric C. M. Van Gorp
Eliford Ngaimisi Tanzania
E.C.M. van Gorp Netherlands
Sabina Mugusi Tanzania
Malte Schütz United States
Nasronudin Nasronudin Indonesia
Vincent Guiyedi France
Paul Natureeba Uganda
Bridget Nzarubara United States
Concepta Merry Ireland
Philip Sasi Tanzania
Eliford Ngaimisi Tanzania
Eric C. M. Van Gorp
Citations per year, relative to Eric C. M. Van Gorp Eric C. M. Van Gorp (= 1×) peers Eliford Ngaimisi

Countries citing papers authored by Eric C. M. Van Gorp

Since Specialization
Citations

This map shows the geographic impact of Eric C. M. Van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. M. Van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. M. Van Gorp more than expected).

Fields of papers citing papers by Eric C. M. Van Gorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. M. Van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. M. Van Gorp. The network helps show where Eric C. M. Van Gorp may publish in the future.

Co-authorship network of co-authors of Eric C. M. Van Gorp

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. M. Van Gorp. A scholar is included among the top collaborators of Eric C. M. Van Gorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. M. Van Gorp. Eric C. M. Van Gorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Smit, Patrick M., Jan W. Mulder, Paul H.M. Smits, et al.. (2011). Low attack rate of novel influenza A (H1N1) virus infection among healthcare workers: a prospective study in a setting with an elaborated containment plan. International Archives of Occupational and Environmental Health. 85(2). 163–170. 3 indexed citations
2.
Heine, Rob ter, Jan W. Mulder, Eric C. M. Van Gorp, et al.. (2010). Intracellular and plasma steady‐state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre‐treated HIV‐infected patients. British Journal of Clinical Pharmacology. 69(5). 475–483. 36 indexed citations
3.
Wagenaar, Jiri F. P., Marga G. A. Goris, Muhammad Hussein Gasem, et al.. (2009). Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. Journal of Infection. 58(6). 425–432. 66 indexed citations
4.
Suharti, Catharina, Eric C. M. Van Gorp, W.M.V. Dolmans, et al.. (2009). Hanta virus infection during dengue virus infection outbreak in Indonesia.. PubMed. 41(2). 75–80. 20 indexed citations
5.
Wagenaar, Jiri F. P., Muhammad Hussein Gasem, Marga G. A. Goris, et al.. (2009). Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis. PLoS neglected tropical diseases. 3(6). e453–e453. 64 indexed citations
6.
Gasem, Muhammad Hussein, Jiri F. P. Wagenaar, Marga G. A. Goris, et al.. (2009). Murine Typhus and Leptospirosis as Causes of Acute Undifferentiated Fever, Indonesia. Emerging infectious diseases. 15(6). 975–977. 40 indexed citations
7.
8.
Kappelhoff, Bregt S, Alwin D. R. Huitema, Pieter L. Meenhorst, et al.. (2005). Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV‐1‐infected patients. British Journal of Clinical Pharmacology. 60(3). 276–286. 15 indexed citations
9.
Mairuhu, Albert T.A., Giuseppe Peri, Tatty E. Setiati, et al.. (2005). Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. Journal of Medical Virology. 76(4). 547–552. 89 indexed citations
10.
Kappelhoff, Bregt S, Alwin D. R. Huitema, Kristel M. L. Crommentuyn, et al.. (2004). Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV‐1‐infected patients. British Journal of Clinical Pharmacology. 59(2). 174–182. 30 indexed citations
11.
Maat, Monique M. R. de, Anthonius de Boer, Cornelis H.W. Koks, et al.. (2004). Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. Journal of Clinical Pharmacy and Therapeutics. 29(2). 121–130. 49 indexed citations
12.
Maat, Monique M. R. de, Rob ter Heine, Jan W. Mulder, et al.. (2003). Incidence and risk factors for nevirapine-associated rash. European Journal of Clinical Pharmacology. 59(5-6). 457–462. 52 indexed citations
13.
Maat, Monique M. R. de, Teun M. Post, D. Jonker, et al.. (2003). Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001. Clinical Drug Investigation. 23(1). 45–53. 1 indexed citations
14.
Maat, Monique M. R. de, Alwin D. R. Huitema, Jan W. Mulder, et al.. (2003). Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals. Clinical Drug Investigation. 23(10). 629–637. 10 indexed citations
15.
Maat, Monique M. R. de, Ron A. A. Mathôt, Agnes I. Veldkamp, et al.. (2002). HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS. Pharmacological Research. 46(3). 295–300. 36 indexed citations
16.
Maat, Monique M. R. de, Richard M. W. Hoetelmans, Ron A. A. Mathôt, et al.. (2001). Drug interaction between St John's wort and nevirapine. AIDS. 15(3). 420–421. 122 indexed citations
17.
Gorp, Eric C. M. Van, Desiderius P.M. Brandjes, & Jan W. ten Cate. (1998). Rational Antithrombotic Therapy and Prophylaxis in Elderly, Immobile Patients. Drugs & Aging. 13(2). 145–157. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliford Ngaimisi Breakdown of academic impact, for papers by E.C.M. van Gorp Breakdown of academic impact, for papers by Sabina Mugusi Breakdown of academic impact, for papers by Malte Schütz Breakdown of academic impact, for papers by Nasronudin Nasronudin Breakdown of academic impact, for papers by Vincent Guiyedi Breakdown of academic impact, for papers by Paul Natureeba Breakdown of academic impact, for papers by Bridget Nzarubara Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by Philip Sasi
Rankless by CCL
2026